Monday Oct 24, 2022

Deprescribing in Patients with Dementia: Less Is More - Frankly Speaking Ep 299

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit:

Overview: Polypharmacy is a burden on patients with dementia. Adverse drug reactions, side effects, the cost, and inappropriate medications that may lead to falls and morbidity/mortality may be conferring more harm than benefit. Unfortunately, 44% of men and 57% of women >65 years take five or more nonprescription and/or prescription medications per day. Join us as we discuss methods for deprescribing polypharmacy in this patient population. 

Episode resource links:

  • Growdon, M. E., Gan, S., Yaffe, K., & Steinman, M. A. (2021). Polypharmacy among older adults with dementia compared with those without dementia in the United States. Journal of the American Geriatrics Society, 69(9), 2464–2475. PMID: 34101822
  • Narayan, S. W., & Nishtala, P. S. (2017). Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review. Drugs & aging, 34(10), 767–776. PMID: 28853000

Guest: Jill M. Terrien PhD, ANP-BC 
Music Credit: Richard Onorato

Copyright 2022 All rights reserved.

Version: 20221013